<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04813263</url>
  </required_header>
  <id_info>
    <org_study_id>P20-408</org_study_id>
    <nct_id>NCT04813263</nct_id>
  </id_info>
  <brief_title>Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia</brief_title>
  <official_title>A Post-marketing Observational Study for Venetoclax in Patients Diagnosed With Acute Myeloid Leukemia in Japan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AbbVie</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AbbVie</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute Myeloid Leukemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood&#xD;
      cell responsible for fighting infections) and is the most common acute leukemia in adults.&#xD;
      This study will assess how safe and effective oral venetoclax is in participants with AML.&#xD;
      Adverse events and change in disease activity will be monitored under routine clinical&#xD;
      practice.&#xD;
&#xD;
      Venetoclax is an approved drug to treat Acute Myeloid Leukemia (AML). Around 400 participants&#xD;
      of any age who are treated with oral venetoclax tablets for AML in accordance with the&#xD;
      approved label will be enrolled in the study across Japan.&#xD;
&#xD;
      Participants will be followed up to 52 weeks following the first dose of oral venetoclax&#xD;
      tablets.&#xD;
&#xD;
      There is expected to be no additional burden for participants in this study. Data will be&#xD;
      collected by information provided by participating physicians based on routine medical&#xD;
      records.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 28, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants With ≥ Grade 3 Neutropenia of Venetoclax Regimens With Unfit Acute Myeloid Leukemia (AML)</measure>
    <time_frame>Up to 52 weeks.</time_frame>
    <description>Percentage of participants with a high grade (≥ Grade 3) protocol specified neutropenia during and after treatment with venetoclax.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Febrile Neutropenia and Thrombocytopenia</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>Percentage of participants with protocol specified febrile neutropenia and thrombocytopenia during and after treatment with venetoclax.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Tumor Lysis Syndrome (TLS)</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>Percentage of participants with protocol specified TLS during and after treatment with venetoclax.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Reported &gt;= Grade 3 Adverse Events (AE)/Adverse Drug Reactions (ADR)</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>Grade 3 and above AE/ADR are serious adverse event (SAE) that results in death, is life-threatening, requires or prolongs hospitalization, results in a congenital anomaly, persistent or significant disability/incapacity or is an important medical event that, based on medical judgment, may jeopardize the subject and may require medical or surgical intervention to prevent any of the outcomes listed above.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Reported Adverse Events (AE)/Adverse Drug Reaction (ADR)</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>An adverse event (AE) is defined as any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. The investigator assessed the relationship of each event to the use of study drug as either definitely related, probably related, possibly related or unrelated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With AE/ADR When Used Concomitantly With CYP3A Inhibitors or Growth Colony Stimulating Factor (G-CSF)</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>An adverse event (AE) is defined as any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. The investigator assessed the relationship of each event to the use of study drug as either definitely related, probably related, possibly related or unrelated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Composite Complete Remission Rate (CR + CRi)</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>Composite Complete remission (CRc) is defined as Complete Remission (CR) + CRi (CR with incomplete blood count recovery) based on protocol criteria.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median Time to Best Response</measure>
    <time_frame>Up to 52 weeks.</time_frame>
    <description>Time to Best Response is measured as the time in months from the first dose of study treatment to the date of first documented documentation of a confirmed response of partial response (PR) or better.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median Treatment Duration</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>Median time for duration of oral venetoclax treatment in participants with Acute Myeloid Leukemia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median Overall Survival</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>Time from the date of first oral Venetoclax intake to the date of death from any cause.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median Duration of Composite Complete Remission</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>Time from the date of first oral Venetoclax intake and the date of the assessment having documented Complete Remission with incomplete Hematologic recovery (CRi).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Acute Myeloid Leukemia (AML)</condition>
  <arm_group>
    <arm_group_label>Participants Treated With Venetoclax</arm_group_label>
    <description>Participants who are administrated venetoclax for treatment of AML under routine clinical practice.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Participants who are prescribed venetoclax for the treatment of Acute Myeloid Leukemia&#xD;
        (AML) in routine clinical practice across Japan.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - All participants who are administered venetoclax for treatment of AML.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ABBVIE INC.</last_name>
    <role>Study Director</role>
    <affiliation>AbbVie</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>AbbVie GK Clinical Trial Registration Desk</last_name>
    <phone>+81-3-4577-1111</phone>
    <email>abbvie_jpn_info_clingov@abbvie.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Akita City Hospital /ID# 240008</name>
      <address>
        <city>Akita-shi</city>
        <state>Akita</state>
        <zip>010-0933</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Asahi General Hospital /ID# 233889</name>
      <address>
        <city>Asahi-shi</city>
        <state>Chiba</state>
        <zip>289-2511</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chiba Aoba Municipal Hospital /ID# 240565</name>
      <address>
        <city>Chiba-shi</city>
        <state>Chiba</state>
        <zip>260-0852</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chiba Rosai Hospital /ID# 238767</name>
      <address>
        <city>Ichihara-shi</city>
        <state>Chiba</state>
        <zip>290-0003</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kameda General Hospital /ID# 241877</name>
      <address>
        <city>Kamogawa-shi</city>
        <state>Chiba</state>
        <zip>296-8602</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital East /ID# 241917</name>
      <address>
        <city>Kashiwa-shi</city>
        <state>Chiba</state>
        <zip>277-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>IUHW Narita Hospital /ID# 240574</name>
      <address>
        <city>Narita City</city>
        <state>Chiba</state>
        <zip>2860124</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Japanese Red Cross Fukuoka Hospital /ID# 241181</name>
      <address>
        <city>Fukuoka-shi</city>
        <state>Fukuoka</state>
        <zip>815-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kurume University Hospital /ID# 240885</name>
      <address>
        <city>Kurume-shi</city>
        <state>Fukuoka</state>
        <zip>830-0011</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gifu Municipal Hospital /ID# 241156</name>
      <address>
        <city>Gifu-shi</city>
        <state>Gifu</state>
        <zip>500-8513</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gifu University Hospital /ID# 241183</name>
      <address>
        <city>Gifu-shi</city>
        <state>Gifu</state>
        <zip>501-1194</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gifu Red Cross Hospital /ID# 240562</name>
      <address>
        <city>Gifu-shi</city>
        <state>Gifu</state>
        <zip>502-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ogaki Municipal Hospital /ID# 239353</name>
      <address>
        <city>Ogaki-shi</city>
        <state>Gifu</state>
        <zip>503-8502</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Japanese Red Cross Takayama Hospital /ID# 240568</name>
      <address>
        <city>高山市</city>
        <state>Gifu</state>
        <zip>506-0025</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gunmaken Saiseikai Maebashi Hospital /ID# 239383</name>
      <address>
        <city>Maebashi-shi</city>
        <state>Gunma</state>
        <zip>371-0821</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hiroshima Red Cross Hospital &amp; Atomic-bomb Survivors Hospital /ID# 240880</name>
      <address>
        <city>Hiroshima-shi</city>
        <state>Hiroshima</state>
        <zip>730-8619</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Steel Memorial Muroran Hospita /ID# 231383</name>
      <address>
        <city>Muroran-shi</city>
        <state>Hokkaido</state>
        <zip>050-0076</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sapporo Hokushin Hospital /ID# 241878</name>
      <address>
        <city>Sapporo-shi</city>
        <state>Hokkaido</state>
        <zip>004-0052</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Aiiku Hospital /ID# 239047</name>
      <address>
        <city>Sapporo-shi</city>
        <state>Hokkaido</state>
        <zip>064-0804</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Homecareclinicn-Consept /Id# 239377</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>003-0803</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sunagawa City Medical Center /ID# 239382</name>
      <address>
        <city>Sunagawa</city>
        <state>Hokkaido</state>
        <zip>073-0164</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sapporo Kiyota Hospital /ID# 231385</name>
      <address>
        <city>札幌市</city>
        <state>Hokkaido</state>
        <zip>004-0831</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ako Central Hospital /ID# 239721</name>
      <address>
        <city>Ako-shi</city>
        <state>Hyogo</state>
        <zip>678-0241</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hyogo Prefectural Amagasaki General Medical Center /ID# 239355</name>
      <address>
        <city>Amagasaki-shi</city>
        <state>Hyogo</state>
        <zip>660-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Itami City Hospital /ID# 233888</name>
      <address>
        <city>Itami-shi</city>
        <state>Hyogo</state>
        <zip>6640006</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shinko Hospital /ID# 233782</name>
      <address>
        <city>Kobe-shi</city>
        <state>Hyogo</state>
        <zip>651-0072</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hyogo Prefectural Nishinomiya Hospital /ID# 239354</name>
      <address>
        <city>Nishinomiya-shi</city>
        <state>Hyogo</state>
        <zip>662-0918</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hyogo College of Medicine College Hospital /Id# 240569</name>
      <address>
        <city>Nishinomiya-shi</city>
        <state>Hyogo</state>
        <zip>663-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hyogo Prefectural Tamba Medical Center /ID# 240884</name>
      <address>
        <city>Tamba-shi</city>
        <state>Hyogo</state>
        <zip>669-3464</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hyogo College of Medicine Sasayama Medical Center /ID# 240888</name>
      <address>
        <city>Tanbasasayama-shi</city>
        <state>Hyogo</state>
        <zip>669-2321</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hyogo Prefectural Awaji Medical Center /ID# 240823</name>
      <address>
        <city>洲本市</city>
        <state>Hyogo</state>
        <zip>656-0021</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Mito Medical Center /ID# 239719</name>
      <address>
        <city>Higashi Ibaraki-gun</city>
        <state>Ibaraki</state>
        <zip>311-3193</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hitachi General Hospital /ID# 239376</name>
      <address>
        <city>Hitachi-shi</city>
        <state>Ibaraki</state>
        <zip>317-0077</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>JA Toride Medical Center /ID# 240573</name>
      <address>
        <city>Toride-shi</city>
        <state>Ibaraki</state>
        <zip>302-0022</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>JCHO Kanazawa Hospital /ID# 239379</name>
      <address>
        <city>Kanazawa-Shi</city>
        <state>Ishikawa</state>
        <zip>920-0013</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sakaide City Hospital /ID# 240563</name>
      <address>
        <city>Sakaide City</city>
        <state>Kagawa</state>
        <zip>7620043</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Imamura General Hospital /ID# 234006</name>
      <address>
        <city>Kagoshima-shi</city>
        <state>Kagoshima</state>
        <zip>890-0064</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kawasaki Municipal Hospital /ID# 241162</name>
      <address>
        <city>Kawasaki-shi</city>
        <state>Kanagawa</state>
        <zip>2100013</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kochi Health Sciences Center /ID# 241182</name>
      <address>
        <city>高知市</city>
        <state>Kochi</state>
        <zip>781-0111</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kumamoto University Hospital /ID# 239720</name>
      <address>
        <city>Kumamoto shi</city>
        <state>Kumamoto</state>
        <zip>8608556</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Kumamoto Medical Center /ID# 240886</name>
      <address>
        <city>Kumamoto-shi</city>
        <state>Kumamoto</state>
        <zip>860-0008</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Kyoto Medical Center /ID# 239092</name>
      <address>
        <city>Kyoto-shi</city>
        <state>Kyoto</state>
        <zip>612-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Takeuchi Hospital /ID# 238750</name>
      <address>
        <city>津市</city>
        <state>Mie</state>
        <zip>514-0031</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Miyagi Cancer Center /ID# 241879</name>
      <address>
        <city>Natori-shi</city>
        <state>Miyagi</state>
        <zip>981-1293</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Sendai Medical Center /ID# 239384</name>
      <address>
        <city>Sendai-shi</city>
        <state>Miyagi</state>
        <zip>983-8520</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nagasaki Goto Chuoh Hospital /ID# 239723</name>
      <address>
        <city>Goto-shi</city>
        <state>Nagasaki</state>
        <zip>853-0031</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>NHO Nagasaki Medical Center /ID# 240571</name>
      <address>
        <city>Omura-shi</city>
        <state>Nagasaki</state>
        <zip>856-8562</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sasebo City General Hospital /ID# 238759</name>
      <address>
        <city>Sasebo-shi</city>
        <state>Nagasaki</state>
        <zip>857-0056</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kaneda Hospital /ID# 238757</name>
      <address>
        <city>Maniwa</city>
        <state>Okayama</state>
        <zip>719-3105</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Okayama University Hospital /ID# 240887</name>
      <address>
        <city>Okayama-shi</city>
        <state>Okayama</state>
        <zip>700-8558</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Japanese Red Cross Okayama Hospital /ID# 240879</name>
      <address>
        <city>Okayama-shi</city>
        <state>Okayama</state>
        <zip>700-8607</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kishiwada City Hospital /ID# 234002</name>
      <address>
        <city>Kishiwada-shi</city>
        <state>Osaka</state>
        <zip>596-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Osaka National Hospital /ID# 238764</name>
      <address>
        <city>Osaka-shi</city>
        <state>Osaka</state>
        <zip>540-0006</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Daini Osaka Police Hospital /ID# 240560</name>
      <address>
        <city>Osaka-shi</city>
        <state>Osaka</state>
        <zip>543-8922</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>TMG Asaka Medical Center /ID# 238761</name>
      <address>
        <city>Asaka-shi</city>
        <state>Saitama</state>
        <zip>351-0023</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saiseikai Shiga Hospital /ID# 239381</name>
      <address>
        <city>Ritto</city>
        <state>Shiga</state>
        <zip>520-3046</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shizuoka Saiseikai Genaral Hospital /ID# 239722</name>
      <address>
        <city>Shizuoka-shi</city>
        <state>Shizuoka</state>
        <zip>422-8527</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tokushima Prefecture Naruto Hospital /ID# 239095</name>
      <address>
        <city>Naruto-shi</city>
        <state>Tokushima</state>
        <zip>772-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Juntendo University Hospital /ID# 239096</name>
      <address>
        <city>Bunkyo-ku</city>
        <state>Tokyo</state>
        <zip>113-8431</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Edogawa Hospital /ID# 239352</name>
      <address>
        <city>Edogawa-ku</city>
        <state>Tokyo</state>
        <zip>133-0052</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fussa Hospital /ID# 240570</name>
      <address>
        <city>Fussa</city>
        <state>Tokyo</state>
        <zip>1970012</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mishuku Hospital /ID# 239378</name>
      <address>
        <city>Meguro-ku</city>
        <state>Tokyo</state>
        <zip>153-0051</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Metropolitan Research and Treatment Center for Blood Disorders /ID# 231384</name>
      <address>
        <city>Setagaya Ward</city>
        <state>Tokyo</state>
        <zip>156-0052</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Japanese Red Cross Medical Center /ID# 239385</name>
      <address>
        <city>Shibuya-ku</city>
        <state>Tokyo</state>
        <zip>150-8935</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>NTT Medical Center Tokyo /ID# 240566</name>
      <address>
        <city>Shinagawa-ku</city>
        <state>Tokyo</state>
        <zip>141-8625</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Toshima Hospital /ID# 240878</name>
      <address>
        <city>板橋区</city>
        <state>Tokyo</state>
        <zip>173-0015</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hiroshima-Nishi Medical Center /ID# 238766</name>
      <address>
        <city>Otake-shi</city>
        <state>Tottori</state>
        <zip>739-0651</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yonago Medical Center /ID# 240572</name>
      <address>
        <city>Yonago-shi</city>
        <state>Tottori</state>
        <zip>683-0006</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kainan Medical Center /ID# 240825</name>
      <address>
        <city>海南市</city>
        <state>Wakayama</state>
        <zip>642-0002</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Inoue Memorial Hospital /ID# 239351</name>
      <address>
        <city>Chiba</city>
        <zip>260-0027</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fujisawa City Hospital /ID# 239375</name>
      <address>
        <city>Fujisawa-shi</city>
        <zip>251-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Harasanshin Hospital /ID# 240881</name>
      <address>
        <city>Fukuoka-shi</city>
        <zip>812-0033</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fukuoka Wajiro Hospital /ID# 238755</name>
      <address>
        <city>Fukuoka</city>
        <zip>811-0213</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saitama City Hospital /ID# 240567</name>
      <address>
        <city>Saitama</city>
        <zip>336-8522</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <link>
    <url>https://www.rxabbvie.com/</url>
    <description>Related info</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 22, 2021</study_first_submitted>
  <study_first_submitted_qc>March 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Myeloid Leukemia (AML)</keyword>
  <keyword>Cancer</keyword>
  <keyword>Venetoclax</keyword>
  <keyword>Venclexta</keyword>
  <keyword>Venclyxto</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Leukemia, Myeloid</mesh_term>
    <mesh_term>Leukemia, Myeloid, Acute</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

